Hypereosinophilic syndrome

  • Dec 07, 2018 www.dovepress.com
    Mepolizumab as the first targeted treatment for eosinophilic granuloma | TCRM – Dove Medical Press
    Read More
  • Dec 03, 2018 sciencetrends.com
    Using Siglec-8 Endocytic Mechanisms To Target Human Eosinophils And Malignant Mast Cells – Science Trends
    Read More
  • Sep 05, 2018 www.businesswire.com
    Knopp Biosciences Announces Year 3 Renewal of NIH Blueprint Grant Award for Advancing KCNQ2 Activators in Rare Neonatal Epilepsy – Business Wire
    Read More
  • Aug 10, 2018 sciencetrends.com
    Activity Of Imatinib In Clonal Extramedullary Myeloid Neoplasms With Eosinophilia – Science Trends
    Read More
  • Aug 06, 2018 www.icd10monitor.com
    Preview of New ICD-11 Codes Revealed – ICD10monitor
    Read More
  • May 25, 2018 www.mdmag.com
    Benralizumab Brings New Approach to Controlling Eosinophilic Asthma – MD Magazine
    Read More
  • May 10, 2018 www.businesswire.com
    Knopp Biosciences Announces Publication of Phase 2 Trial Results of dexpramipexole in Hypereosinophilic Syndromes (HES) in Blood – Business Wire
    Read More
  • Sep 06, 2017 www.businesswire.com
    Knopp Biosciences and APFED Announce Partnership to Advance Awareness of Hypereosinophilic Syndromes – Business Wire
    Read More
  • Mar 21, 2017 www.businesswire.com
    Knopp Biosciences Announces Election of Biotech Executive Shane Kovacs to Board of Managers – Business Wire
    Read More

Connect. Empower. Inspire.